Annual Total Liabilities
$1.07 B
+$187.44 M+21.15%
December 31, 2023
Summary
- As of February 7, 2025, ASND annual total liabilities is $1.07 billion, with the most recent change of +$187.44 million (+21.15%) on December 31, 2023.
- During the last 3 years, ASND annual total liabilities has risen by +$900.13 million (+518.73%).
- ASND annual total liabilities is now at all-time high.
Performance
ASND Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.33 B
+$173.30 M+14.98%
September 30, 2024
Summary
- As of February 7, 2025, ASND quarterly total liabilities is $1.33 billion, with the most recent change of +$173.30 million (+14.98%) on September 30, 2024.
- Over the past year, ASND quarterly total liabilities has increased by +$328.32 million (+32.77%).
- ASND quarterly total liabilities is now at all-time high.
Performance
ASND Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ASND Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.1% | +32.8% |
| 3 y3 years | +518.7% | +441.9% |
| 5 y5 years | +2311.7% | +1542.4% |
ASND Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +371.1% | at high | +483.7% |
| 5 y | 5-year | at high | +1103.8% | at high | +1562.0% |
| alltime | all time | at high | +8480.5% | at high | >+9999.0% |
Ascendis Pharma A/S Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.33 B(+15.0%) |
| Jun 2024 | - | $1.16 B(+3.0%) |
| Mar 2024 | - | $1.12 B(+4.7%) |
| Dec 2023 | $1.07 B(+21.2%) | $1.07 B(+7.1%) |
| Sep 2023 | - | $1.00 B(+21.5%) |
| Jun 2023 | - | $824.82 M(-5.3%) |
| Mar 2023 | - | $871.34 M(-1.7%) |
| Dec 2022 | $886.22 M(+288.9%) | $886.22 M(+9.7%) |
| Sep 2022 | - | $807.81 M(+7.6%) |
| Jun 2022 | - | $751.05 M(-4.5%) |
| Mar 2022 | - | $786.23 M(+245.0%) |
| Dec 2021 | $227.90 M(+31.3%) | $227.90 M(-7.2%) |
| Sep 2021 | - | $245.52 M(+25.5%) |
| Jun 2021 | - | $195.59 M(+2.7%) |
| Mar 2021 | - | $190.49 M(+9.8%) |
| Dec 2020 | $173.53 M(+94.6%) | $173.53 M(+56.3%) |
| Sep 2020 | - | $110.99 M(+18.2%) |
| Jun 2020 | - | $93.87 M(+17.3%) |
| Mar 2020 | - | $80.05 M(-10.2%) |
| Dec 2019 | $89.19 M | $89.19 M(+10.1%) |
| Sep 2019 | - | $81.00 M(-22.6%) |
| Jun 2019 | - | $104.70 M(+105.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $50.85 M(+14.2%) |
| Dec 2018 | $44.52 M(+56.1%) | $44.52 M(+23.5%) |
| Sep 2018 | - | $36.06 M(-14.9%) |
| Jun 2018 | - | $42.36 M(+97.3%) |
| Mar 2018 | - | $21.47 M(-24.7%) |
| Dec 2017 | $28.51 M(+100.4%) | $28.51 M(+21.7%) |
| Sep 2017 | - | $23.43 M(+28.5%) |
| Jun 2017 | - | $18.23 M(-4.9%) |
| Mar 2017 | - | $19.17 M(+34.7%) |
| Dec 2016 | $14.23 M(+13.7%) | $14.23 M(+2.7%) |
| Sep 2016 | - | $13.86 M(+5.3%) |
| Jun 2016 | - | $13.15 M(+7.8%) |
| Mar 2016 | - | $12.20 M(-2.5%) |
| Dec 2015 | $12.51 M(-20.0%) | $12.51 M(+16.5%) |
| Sep 2015 | - | $10.74 M(-22.6%) |
| Jun 2015 | - | $13.89 M(+6.0%) |
| Mar 2015 | - | $13.10 M(-16.3%) |
| Dec 2014 | $15.64 M(-44.5%) | $15.64 M(-6.8%) |
| Sep 2014 | - | $16.79 M(-40.4%) |
| Dec 2013 | $28.17 M(-10.7%) | $28.17 M |
| Dec 2012 | $31.54 M(+7.8%) | - |
| Dec 2011 | $29.25 M | - |
FAQ
- What is Ascendis Pharma A/S annual total liabilities?
- What is the all time high annual total liabilities for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual total liabilities year-on-year change?
- What is Ascendis Pharma A/S quarterly total liabilities?
- What is the all time high quarterly total liabilities for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly total liabilities year-on-year change?
What is Ascendis Pharma A/S annual total liabilities?
The current annual total liabilities of ASND is $1.07 B
What is the all time high annual total liabilities for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual total liabilities is $1.07 B
What is Ascendis Pharma A/S annual total liabilities year-on-year change?
Over the past year, ASND annual total liabilities has changed by +$187.44 M (+21.15%)
What is Ascendis Pharma A/S quarterly total liabilities?
The current quarterly total liabilities of ASND is $1.33 B
What is the all time high quarterly total liabilities for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly total liabilities is $1.33 B
What is Ascendis Pharma A/S quarterly total liabilities year-on-year change?
Over the past year, ASND quarterly total liabilities has changed by +$328.32 M (+32.77%)